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Taurine Treatment Modulates 
Circadian Rhythms in Mice Fed A 
High Fat Diet
Ana Lucia C. Figueroa1, Hugo Figueiredo1, Sandra A. Rebuffat1,2, Elaine Vieira2,3,* & 
Ramon Gomis1,2,4,*
Close ties have been made among certain nutrients, obesity, type 2 diabetes and circadian clocks. 
Among nutrients, taurine has been documented as being effective against obesity and type 2 diabetes. 
However, the impact of taurine on circadian clocks has not been elucidated. We investigated whether 
taurine can modulate or correct disturbances in daily rhythms caused by a high-fat diet in mice. Male 
C57BL/6 mice were divided in four groups: control (C), control + taurine (C+T), high-fat diet (HFD) 
and HFD + taurine (HFD+T). They were administered 2% taurine in their drinking water for 10 weeks. 
Mice were euthanized at 6:00, 12:00, 18:00, and 24:00. HFD mice increased body weight, visceral fat 
and food intake, as well as higher levels of glucose, insulin and leptin, throughout the 24 h. Taurine 
prevented increments in food intake, body weight and visceral fat, improved glucose tolerance and 
insulin sensitivity and reduced disturbances in the 24 h patterns of plasma insulin and leptin. HFD 
downregulated the expression of clock genes Rev-erbα, Bmal1, and Per1 in pancreatic islets. Taurine 
normalized the gene and protein expression of PER1 in beta-cells, which suggests that it could be 
beneficial for the correction of daily rhythms and the amelioration of obesity and diabetes.
Diverse physiological and behavioral circadian oscillations such as sleep-wake cycles and the secretion of hor-
mones and metabolism are controlled by the molecular clock that generates daily rhythms in mammals. This 
clock allows for adaptation to periodic changes in the environment, according to light and dark cycles1,2.
Circadian rhythms are controlled by cell-autonomous and self-sustained oscillators, which depend on the 
transcription-translation, autoregulatory feedback loop of specific clock genes. The positive limb is formed by 
transcription factors, including Bmal1/Clock, that activates the transcription of Per and Cry genes, which drive 
the negative limb and inhibit the activity of Bmal1/Clock, generating rhythmic oscillations of gene expression. 
An additional regulation is driven by the nuclear receptors Reverb’s and Ror’s, which repress and activate Bmal1, 
respectively3–5. Mammalian circadian clocks are composed of a central clock located in the suprachiasmatic 
nucleus (SCN) in the hypothalamus and several peripheral clocks found in many tissues; including the pancreas, 
the liver, adipose tissue and muscle6–12. Peripheral clocks contribute to global energy metabolism and participate 
in local metabolic functions, such as those involved in glucose and lipid homeostasis. Among peripheral clocks, 
the pancreatic clock is crucial for controlling the function of pancreatic beta-cells. Ablation of Clock and Bmal1 
with genetic manipulation led to the development of diabetes in mice, whereas Rev-erbα gene silencing led to 
impairments in beta- and alpha-cell function8,10,11,13.
Other factors apart from genetic manipulation can also disrupt clock gene expression in peripheral tissues. For 
instance, nutritional insults such as HFD feeding disrupted the expression of Rev-erbα, Clock, Per1, and Per2 in 
mouse pancreatic islets, followed by disruption of the pattern of insulin secretion10. In addition, nutrient signal-
ing, by glucose or amino acids may act as a training agent of SCN and peripheral clocks, leading to tissue-specific 
differences in the expression of clock genes14–16. Dietary supplementation of the amino sulfonic acid taurine was 
found to improve whole body glucose control particularly, and to be useful in both prevention and treatment 
for metabolic complications in obese rodents17,18. In this point, taurine is considered an essential nutrient due 
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to the diverse therapeutic effects at different levels and could be proposed as a supplement in obesity treatment. 
Otherwise important external stimuli, like nutrients, synchronize the circadian clock, however the effect of tau-
rine on daily rhythms of hormones and on the expression of clock genes has never been studied before. Therefore, 
the aim of this study was to determine whether taurine treatment can modulate and prevent disturbances of daily 
rhythms of hormones and the expression of clock genes caused by HFD.
Results
Effects of taurine treatment on body weight, visceral fat and food intake. We first measured 
body weight progression from the first week of treatment. Body weight was similar between the groups until the 
5th week of treatment. In the HFD group, body weight increased from the 5th week of treatment in both HFD and 
HFD+ T treated mice, as compared to controls. However, from the 8th to the 10th week of treatment, mice fed 
with HFD+ T prevented the increase in body weight, compared to mice fed with HFD until the end of treatment 
(Fig. 1A). After 10 weeks of treatment, visceral fat weight was comparable between the C and C+ T groups. As 
expected, mice treated with a HFD showed a significant increase in visceral fat, compared to the C group, whereas 
mice treated with HFD+ T had a decrease in visceral fat, compared to the HFD group (Fig. 1B). Interestingly, 
HFD-treated mice had increased food intake already at the first week of treatment with a peak of food con-
sumption at the second week and a sustained elevation of food intake until the end of treatment. On the other 
hand, HFD+ T mice had decreased food intake already at the first week compared to the HFD group (Fig.1C). 
Measurements of food intake at the end of treatment (10th week) during the light cycle was similar between C and 
C+ T groups and increased during the dark cycle in both groups (P < 0.0001, respectively). In contrast, mice fed 
a HFD exhibited an increase in food intake during both light and dark cycles, as compared to C group (Fig. 1D). 
Strikingly, taurine decreased food intake in both light and dark cycles. Water intake was similar in all experimen-
tal groups at the 10th week of treatment (Fig. 1E). The effects of the HFD and taurine treatment after 10 weeks on 
body weight gain, visceral fat and food intake and their interactions are also shown in Table 1. There was no effect 
of taurine treatment on body weight, visceral fat and food intake in the control group (Table 1). However, the effect 
of HFD alone when compared to the control group showed that this diet increased body weight, visceral fat and 
food intake. On the other hand, taurine treatment in the HFD group was able to decrease body weight, visceral 
fat and food intake although the treatment could not decrease these parameters at the level of the control group 
(Table 1). To check the effect of taurine at the beginning of the treatment we next measured body weight, visceral 
fat, water and food intake at the first week of treatment. There was no difference in body weight, visceral fat and 
water intake in all experimental groups (Supplementary Fig. 1A–C, respectively). Strikingly, mice fed a HFD had 
an increase in food intake during the light and dark cycles already at the first week of treatment whereas taurine 
was able to prevent the increase in food intake caused by HFD in both light and dark cycles (Supplementary 
Fig. 1D). Moreover, one week of HFD treatment led to glucose intolerance (Supplementary Fig. 2A) 
and decreased insulin sensitivity (Supplementary Fig. 2C) but taurine treatment in mice fed a HFD had a small 
effect on glucose tolerance and insulin sensitivity with no statistically significant results when calculating the area 
under the curve (Supplementary Fig. 2B,D respectively). These results showed that one week of taurine treatment 
in mice treated with HFD can decrease food intake during light and dark cycles even before any change in body 
weight and visceral fat. In addition, prolonged taurine treatment can modulate the increase in body weight, vis-
ceral fat and food intake caused by HFD feeding.
Effects of taurine treatment on daily glucose, insulin and leptin levels. The effect of taurine treat-
ment (C+ T group) on the daily glucose levels was evident at time 12:00, with lower levels than in the C group 
(Fig. 2A). As expected, blood glucose levels were elevated at 18:00 and 24:00 in the HFD group, compared to the C 
group (Fig. 2A). However, mice treated with HFD+ T exhibited lower glucose levels throughout the 24 h period as 
compared to mice treated only with HFD (Fig. 2A). Mesor analysis of the data confirmed the hypoglycemic effect 
of taurine during HFD treatment by decreasing glucose levels to the same levels of the control group (Table 2).
Plasma insulin levels were similar in the C group at all time points measured, but increased in the C+ T group 
at 24:00 (Fig. 2B). In contrast, insulin levels were continuously elevated throughout the 24 h period in the HFD 
group as compared to the C group. Interestingly, HFD+ T decreased the overall levels of plasma insulin through-
out the 24 h period and increased plasma insulin levels at 24:00 (Fig. 2B).
Control mice exhibited statistically significant variations in plasma leptin concentrations with decreased val-
ues at 12:00, and a peak at 24:00 (P < 0.01 and P < 0.05). The C+ T group exhibited the same variations in plasma 
leptin, but the peak occurred at 18:00 (Fig. 2C). Interestingly, HFD mice disrupted the daily pattern of leptin, 
with no decrease in leptin levels at 12:00 and a peak of leptin at 18:00 (P < 0.05). Taurine treatment prevented the 
disruption of daily plasma leptin caused by HFD, decreased leptin levels at 12:00 (P < 0.01) and a peak of leptin 
from 12:00 to 24:00 (P < 0.01). Confirming these results, the mesor and amplitude values showed that taurine 
decreased insulin and leptin levels in mice treated with a HFD (Table 2). Our results demonstrated that taurine 
supplementation in mice fed a HFD can restore the 24 h pattern of plasma leptin levels.
Effects of taurine on glucose tolerance and insulin sensitivity. Glucose tolerance was simi-
lar between C and C+ T mice, showing no differences between the groups. As expected, HFD mice displayed 
impaired glucose tolerance, evident in the total area under the curve (AUC) as compared to control mice 
(Fig. 3A,B). Taurine supplementation in HFD-fed mice prevented glucose intolerance caused by a HFD, as indi-
cated in the total area under the curve (AUC) (Fig. 3B). There were no differences in insulin sensitivity between 
C and C+ T mice, but the HFD group exhibited impaired insulin sensitivity (Fig. 3C). Ten weeks of taurine treat-
ment were sufficient to prevent insulin resistance caused by HFD feeding, as shown in the total area under the 
curve (AUC) (Fig. 3C,D). Plasma insulin levels during the ipGTT showed a significant decrease in plasma insulin 
levels in the C+ T group at 15 min. In accordance with the ipGTT results, the HFD group displayed elevated 
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insulin levels at 30 and 60 min, as compared to the C group. Interestingly, taurine treatment reduced insulin levels 
at 30 min and 60 min in animals treated with HFD (Fig. 3E), as indicated in the total area under the curve (AUC) 
(Fig. 3F).
Effects of taurine on daily insulin secretion in vitro. To check whether the modulation of taurine 
on the 24 h pattern of insulin secretion in vivo reflects changes in insulin secretion in vitro, we next performed 
glucose-stimulated insulin secretion from fresh isolated islets at 6:00, 12:00, 18:00, and 24:00. Isolated islets from 
control mice exhibited no changes in insulin secretion during the 24 h period at low glucose concentrations. 
Islets from the C+ T group had increased insulin secretion at 18:00 when stimulated with basal glucose concen-
trations (Fig. 4A). When control islets were stimulated with high glucose concentrations, we could observe the 
Figure 1. Effects of taurine treatment on body weight, visceral fat, food intake. Mice were treated with chow 
diet  (C), Chow + Taurine  (C + T), High-fat diet  (HFD) or HFD + Taurine  (HFD + T) for 10 
weeks. (A) Body weight progression from the first day of taurine treatment until the 10th week of treatment in 
mice fed with chow or HFD. (n = 8–10 mice per group). Differences between C vs HFD (*P < 0.05); HFD vs 
HFD+T (#P < 0.05, ##P < 0.01). (B) Visceral fat weight after 10 weeks of taurine treatment in mice fed with 
chow or HFD. Differences between C vs HFD (*P < 0.05); HFD vs HFD+T (#P < 0.05). (n = 8–10 mice per 
group). (C) Food intake progression from the first week until the 10th week of treatment. Differences between  
C vs HFD *P < 0.05. **P < 0.001, ***P < 0.0001. Differences between HFD vs HFD+ T (#P < 0.05, ##P < 0.001). 
(D) Food intake at 10th week of treatment during the light and dark cycle. Food was measured by weighing the 
food consumption separately during the day (from 8:00 to 20:00) and the food consumption during the night 
(from 20:00 to 8:00). Differences between C vs HFD (***P < 0.001); and HFD vs HFD+ T (##P < 0.01). (E) Water 
Intake at 10th week of treatment. Data are expressed as mean ± SEM.
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effect of the time of the day on insulin secretion. Glucose-stimulated insulin secretion had a peak of secretion 
at 18:00 and maintained high levels at 24:00 as compared to secretion at 6:00 and 12:00. The same pattern of 
glucose-stimulated insulin secretion was observed in islets from the C+ T group, however, taurine treatment 
augmented glucose-stimulated insulin secretion during the dark cycle, as compared to secretion from control 
islets (Fig. 4A). When islets from HFD mice were stimulated with high glucose concentrations, we found altera-
tions in insulin secretion according to the time of day. Islets isolated at 6:00 lost the stimulatory effect of glucose 
compared to control islets (Fig. 4B). The nocturnal increase of glucose-stimulated insulin secretion was advanced 
to 12:00, exhibiting an increase in insulin secretion already at 12:00 and keeping high levels throughout the 
dark cycle. We could not detect the effect of the time of day in isolated islets from mice treated with HFD+ T on 
glucose-stimulated insulin secretion. However, islets from HFD+ T decreased glucose-induced insulin secretion 
at 12:00, 18:00 and 24:00, as compared to the HFD group (Fig. 4B). These results indicate that HFD disrupts 
in vitro glucose-stimulated insulin secretion that could not be prevented by taurine treatment.
Effects of taurine on the clock gene expression in pancreatic islets. The islet exhibits oscillations 
in clock gene expression throughout the day and alterations in clock gene expression impaired beta-cell function 
leading to the development of diabetes8–10,19. Therefore, we next checked whether taurine could modulate the 
daily pattern of Bmal1, Clock, Rev-erbα, Per1 and Per2 expression in isolated pancreatic islets. The expression of 
Clock was similar in control or C+ T islets (Fig. 5A). There was no effect of HFD on Clock expression, but taurine 
treatment in the HFD group increased Clock expression at 18:00 (Fig. 5A). This effect was evident by the mesor 
and amplitude values showing an increase in the HFD+ T group (Table 3). The 24 h pattern of Bmal1 in control 
islets showed the highest peak at 6:00 and the lowest at 18:00 (Fig. 5B). Taurine treatment in mice fed with chow 
diet showed an increase in mesor values detected by the cosinor analysis. Islets from HFD downregulated Bmal1 
expression at 6:00, as compared to control islets, whereas HFD+ T islets exhibited increased Bmal1 expression at 
24:00 (Fig. 5B). Cosinor analysis showed that HFD feeding decreased the mesor and amplitude of Bmal1 expres-
sion and that taurine treatment restored mesor values of Bmal1 expression and changed the acrophase (from 6 in 
all groups to 23 h) in mice treated with HFD (Table 3). Rev-erbα expression showed a similar pattern of expres-
sion in C and C+ T islets, with a peak of expression at 12:00 and 18:00 and a decrease at 6:00 and 24:00 (Fig. 5C). 
HFD disrupted 24 h expression by upregulating Rev-erbα expression at 6:00 and downregulating at 18:00, com-
pared to C islets, while there was no effect of taurine in HFD+ T islets on Rev-erbα expression (Fig. 5C). Cosinor 
analysis confirmed this data, showing a decrease in the values of the mesor in the HFD group, in relation to the 
C group (Table 3). Per2 expression had a peak of expression at 18:00 in control islets in all experimental groups, 
with increased Per2 levels in the C+ T group at 12:00 compared to control. There was no effect of diet and tau-
rine among the other groups (Fig. 5D). In C and C+ T islets, Per1 showed changes during the 24 h pattern of 
expression with the highest peak at 18:00 (Fig. 5E). HFD downregulated Per1 expression at 6:00 and at 18:00, as 
compared to C islets. Interestingly, taurine treatment during HFD feeding restored the circadian pattern of Per1 
expression to the same expression levels as in the C islets (Fig. 5E). Cosinor analysis confirmed the inhibitory 
effect of HFD on Per1 expression and in the amplitude of the gene, as well as the preventive effect of taurine on 
the Per 1 expression and Per1 amplitude (Table 3). These results demonstrated that taurine treatment during HFD 
feeding can prevent the disruption of Per1 expression in pancreatic islets.
PER1 protein expression in pancreatic islets. Since taurine modulated the expression of Per1 in islets, 
we next quantified protein levels of PER1 in pancreatic islets isolated at 18:00 and 24:00 after 10 weeks of treat-
ment. Confirming our results, the HFD decreased the protein expression of PER1 at 18:00, and taurine restored 
PER1 protein levels in islets from mice treated with a HFD (Fig. 6A). As expected, there was no difference in 
PER1 protein expression at 24:00, confirming our results on gene expression (P = 0.46).
To further validate these results, immunofluorescence was performed in whole fresh isolated pancreatic islets 
of mice after 10 weeks of treatment. We analyzed total percentage of PER1-positive stained cells within the islet 
and found a higher tendency for PER1 staining in C+ T islets (P = 0.09), as compared to control islets (Fig. 6B). 
Moreover, C+ T islets showed a statistically significant increase in the percentage of total PER1 in insulin-positive 
cells when compared with C islets (Fig. 6B). Since PER1 is a transcription factor that can be localized in the 
Variable
Groups p Value interactions
C C+T HFD HFD+T C vs C+T C vs HFD HFD vs HFD+T
Body weight gain (g) 4 ± 0,8 3,7 ± 0,5 14,5 ± 0,9*** 8,7 ± 0,8## 0,76 0,001 0,01
Visceral fat (mg) 596,4 ± 109,7 673,5 ± 112,6 1866,3± 183,5*** 1229,8 ± 214,7# 0,63 0,001 0,03
Final Food intake 
(kcal/day/mouse) 6,4 ± 0,3 5,9 ± 0,3 11,05 ± 0,4
*** 8,5 ± 0,4# 0,32 0,001 0,05
Differences between groups
 C vs C+ T ns (not significant)
 C vs HFD ***p < 0.05
 HFD vs HFD+ T #p < 0.05
##p < 0.01
Table 1.  Effects of taurine treatment on body weight, visceral fat and food intake. Effect of HFD and taurine 
after 10 weeks of treatment. Values shown are the means ± SEM. (Two-way ANOVA followed by Bonferroni 
post hoc test).
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cytoplasm and/or nucleus, we accessed the cell localization of PER1 in isolated islets. We found similar nuclear 
PER1 localization in the beta-cells of the C and C+ T groups (Fig. 6B). However, when measuring nuclear staining 
in all islet cells, PER1 expression was upregulated by taurine in the control group (Fig. 6B).
Consistent with our results on gene expression, the HFD downregulated PER 1 protein expression as com-
pared to C islets (P = 0.002). When we compared islets from HFD and HFD+ T, we found an increase in total 
PER1-positive staining with taurine (Fig. 6C). Moreover, insulin-positive cells from HFD+ T islets presented 
higher total PER1 labelling than islets from HFD mice (Fig. 6C). We observed an increased staining of nuclear 
PER1 from HFD+ T islets and nuclear PER1 staining when analyzed in total islet cells, compared to islets from 
HDF mice (Fig. 6C). Thus, these results demonstrated that HFD downregulated PER1 protein and gene expres-
sion, whereas taurine upregulated PER1 in mice fed a HFD.
Figure 2. Effects of taurine treatment on daily glucose, insulin and leptin levels. (A) 24h time course 
measurements of plasma glucose concentrations after 10 weeks of taurine treatment in mice fed a chow diet or 
HFD.  (C),  (C+ T)  (HFD) and  (HFD+ T). Differences between C vs C+ T (&P < 0.05). 
Differences between C vs HFD (*P < 0.05, **P < 0.001). Differences between HFD vs HFD+ T (#P < 0.05 
###P < 0.001). (n = 8–10 mice per group). (B) 24 h time course measurements of plasma insulin concentrations 
after 10 weeks of taurine treatment in mice fed a chow diet or HFD.  (C),  (C+ T)  (HFD) and  
(HFD+ T). Differences between C vs C+ T (&P < 0.05). Differences between C vs HFD (***P < 0.001). 
Differences between HFD vs HFD+ T (#P < 0.05, ##P < 0.01) (n = 8–10 mice per group). (C) 24 h time course 
measurements of plasma leptin concentrations after 10 weeks of taurine treatment in mice fed a chow diet or 
HFD  (C),  (C+ T)  (HFD) and  (HFD+ T). Differences between C vs C+ T (&&P < 0.01). 
Differences between C vs HFD (**P < 0.05, ***P < 0.001). Differences between HFD vs HFD+ T (#P < 0.05, 
##P < 0.01). (n = 8–10 mice per group). The black bars refers on the top of the figures to the dark cycle and the 
white bars to the light cycle.
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Effects of taurine on the clock gene expression on visceral adipose tissue. We next checked 
whether taurine could modulate the daily pattern of Bmal1, Clock, Rev-erbα, Per1 and Per2 expression in vis-
ceral adipose tissue. The expression of Clock was similar in control or C+ T islets (Supplementary Fig. 3A). 
However, HFD disrupted Clock expression in visceral adipose tissue by increasing Clock expression at 6:00 and 
at 18 and 24:00. Taurine treatment was able to restore the Clock expression at 18:00 and 24:00 in mice fed with 
HFD (Supplementary Fig. 3A). Bmal1 expression in control group had a peak of expression at 6:00 and 24:00, and 
was decreased in C+ T group at 6:00 and 24:00. Bmal1 expression was downregulated by HFD at 12:00 and 24:00 
but taurine treatment had no effect on Bmal1 expression (Supplementary Fig. 3B). The expression of Rev-erbα in 
visceral adipose tissue was decreased at 6:00 and increased at 24:00 by HFD (Supplementary Fig. 3C) and taurine 
treatment could normalize Rev-erbα mRNA levels at 6:00 and 24:00. Per1 expression was also decreased at 6:00 
in visceral adipose tissue from mice fed a HFD but in this case, taurine treatment had no effect on Per1 expres-
sion in visceral adipose tissue (Supplementary Fig. 3D). Per 2 expression was increased in C+ T group at 24:00 
compared to control. In addition, HFD disrupted Per2 expression by upregulating the expression of this gene 
at 6:00 and 24:00 whereas taurine treatment restored Per2 expression at both 6 and 24:00 in mice treated with 
HFD (Supplementary Fig. 3E). Thus, taurine treatment during HFD feeding can prevent the disruption of Clock, 
Rev-erbα and Per2 expression in visceral adipose tissue.
Discussion
Close ties are found among nutrients, metabolic diseases and circadian clocks. This paper is the first to study 
the modulation of circadian rhythms by taurine. Taurine is one of the most abundant sulphonic acids in all tis-
sues, and the efficacy of taurine administration against obesity and type 2 diabetes has been well documented. 
However, the impact of taurine on circadian clocks has not been studied before. In our results, HFD treatment 
significantly increased body weight and visceral fat and decreased glucose tolerance and insulin sensitivity, as 
previously established in other studies10,20,21. Taurine treatment prevents increases in body weight, glucose intol-
erance, insulin resistance and reduced visceral fat, according to studies where taurine had several beneficial met-
abolic effects in different models of type 2 diabetes and obesity22–26.
It has been demonstrated that consumption of a HFD disrupts the 24 h pattern of circulating levels of several 
hormones and the behavioural and molecular circadian rhythms in rodents10,27,28. We found that HFD increments 
food intake already at the first week of treatment during the light and dark cycles and that taurine treatment pre-
vents HFD-increased food intake during both resting and active periods at the first and at 10th week of treatment. 
Since the effect on food intake occurs already at the first week of treatment before any changes in body weight and 
fat weight this, suggest an early a central effect of taurine on food intake. Indeed, this effect could be explained 
by a direct effect of taurine on the hypothalamic regions that control food intake. Taurine has an anorexigenic 
action in the hypothalamus and modulates hypothalamic neuropeptide expression29,30. Another possibility could 
be a direct effect of taurine on the secretion of hormones that regulate food intake, including insulin and leptin. 
Indeed, we demonstrate that taurine treatment in mice fed with a HFD decreased the overall levels of plasma 
insulin during 24 h; it also decreased the insulin levels during the glucose tolerance test and diminished glucose 
stimulated insulin secretion in isolated islets. The 24 h pattern of plasma leptin levels was also reduced in mice 
treated with HFD+ T, which could be explained by the decrease in visceral fat in these animals.
Diurnal variations in glucose, leptin and plasma insulin levels are subjected to daily cycles, which are altered 
in diabetes and obesity10,31–37. Our results confirm the disruption of leptin levels by HFD feeding and provide 
new insights regarding the preventive effect of taurine on leptin levels in animals fed a HFD. The mechanisms 
underlying the preventive effects of taurine on leptin levels are not yet known, but it is possible that taurine, by 
regulating insulin levels, could normalize the 24 h pattern leptin levels. In fact, daily leptin levels were shown to 
be dependent on insulin levels in mice38.
The daily pattern of insulin was shown to be independent of the temporal distribution of feeding in 
rats34, and an intrinsic circadian oscillator composed of clock and clock-controlled genes was found in mice, 
R2 Mesor p Value Amplitude p Value Acrophase p Value
C C+T HFD HFD+T C C+T HFD HFD+T
C vs 
C+T
C vs 
HFD
HFD vs 
HFD-T C C+T HFD HFD+T
C vs 
C+T
C vs 
HFD
HFD vs 
HFD-T C C+T HFD HFD+T
C vs 
C+T
C vs 
HFD
HFD vs 
HFD-T
Glucose 0,028 0,02 0,001 0,003 123,7 116&& 136,5** 121,17### 0,01 0,005 0,001 11,6 12,9 12,1 9,4 0,76 0.85 0.25 11,0 23,0&&& 17,0 17,0 0,001 0,96 0,9
Insulin 0,24 0,38 0,01 0,60 1,4 1,5 9,3*** 2,9## 0,87 0,001 0,007 0,6 0,7 3,3*** 1,8# 0,7 0.001 0.04 23,0 23,0 17,0 23,0 0,77 0,35 0,9
Leptin 0,49 0,34 0,06 0,48 3,5 4,6 64,3*** 38,9## 0,11 0,001 0,007 2,6 2,5 27,4*** 15,8## 0,61 0.001 0.01 23,0 23,0 17,0 23,0 0,32 0,68 0,2
Differences between groups
C vs C+ T
&&p < 0.01
&&&p < 0.001
C vs HFD
**p < 0.01
***p < 0.001
HFD vs 
HFD+ T
#p < 0.05
##p < 0.01
###p < 0.001
Table 2.  Cosinor analysis of the 24 h expression of metabolic parameters. Cosinor analysis including 
goodness of the fit (R2), mesor, amplitude, and acrophase of the 24 h profiles of plasma glucose, insulin and 
leptin. Next Two-way ANOVA shows the difference between groups in mesor, amplitude and acrophase 
respectively. Values shown are the means ± SEM.
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rats and humans8–10,39,40. Although we could not detect a 24 h pattern of insulin levels in our in vivo results, 
glucose-stimulated insulin secretion in isolated islets changed according to the time of day. Insulin secretion 
in control islets stimulated with glucose were elevated during the active period and reduced during the resting 
period, with enhanced circadian insulin secretion in mice fed a chow diet and treated with taurine. The 24 h 
pattern of glucose-stimulated insulin secretion was altered in islets from HFD mice, which showed a peak in 
insulin secretion during the resting period, consistent with the increase in food intake during the light cycle in 
these mice. Surprisingly, taurine treatment abolished the daily pattern of glucose-stimulated insulin secretion in 
isolated islets from HFD-fed mice. The reason is not known, but it could be possible that taurine could modulate 
important metabolic genes involved in the regulation of insulin secretion and beta-cell mass, as shown in previ-
ous studies with taurine supplementation in obese animals41,42.
Figure 3. Effects of taurine treatment on glucose tolerance and insulin sensitivity. Glucose tolerance test  
(A)  (C),  (C+ T),  (HFD) and  (HFD+ T). Differences between C vs HFD (*P < 0.05, **P < 0.01 
***P < 0.001); HFD vs HFD+ T (#P < 0.05, ###P < 0.001). (n = 8–10 mice per group). (B) Area under the curve 
(AUC). Differences between C vs HFD (***P < 0.001) and HFD vs HFD+ T (**P < 0.01). (C) Insulin tolerance 
test (n = 8–10). Differences between C vs HFD (**P < 0.01 ***P < 0.001); HFD vs HFD+ T (#P < 0.05, 
###P < 0.001). (D) Area under the curve (AUC), (***P < 0.001). (E) Plasma insulin measured during the glucose 
tolerance test at 0, 15, 30, and 60 min (n = 5). Differences between C vs HFD (***P < 0.001); HFD vs HFD+ T 
(#P < 0.05, ###P < 0.001) and C vs C+ T (&&P < 0.01). (n = 8–10 mice per group).
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The islet clock exhibits oscillations in clock gene expression throughout the day in different species, and alter-
ations in their expression leads to impairments in insulin secretion8,10,13,43,44. Our results show that the HFD dis-
rupts the expression of Bmal1, Rev-erb alpha and Per1 genes in isolated islets, whereas taurine supplementation 
could not rescue Bmal1 and Rev-erbα expression. An interesting finding of the present study is that taurine could 
prevent the downregulation of Per1 levels caused by a HFD in isolated islets. This was evident in measurements of 
gene and protein expression, mainly in the insulin-positive cells. The increase in percentage of PER1 expression 
in insulin-positive cells was detected in the nuclear fraction of these cells, suggesting that PER1 could be a target 
of taurine. The role of PER1 in the regulation of insulin secretion has never been demonstrated, but it could be 
possible that taurine modulation of PER1 expression could regulate insulin secretion.
Adipose tissue clocks have important role in maintenance of lipid homeostasis and are related with features of 
obesity. The expression of clock genes in visceral adipose tissue were altered during HFD feeding. Similar peaks 
according to the diurnal expression of Bmal1, Rev-erbα and Per 1, Per 2 during HFD were comparable with pre-
vious works respectively28,45. Taurine changed the expression of Clock, Rev-erbα and Per2, these effects of taurine 
could be tissue-dependent and peripheral clocks may be possible targets of this sulfonic acid during obesity.
Considering the different effects of in vivo taurine treatment on whole body metabolism, it is difficult that one 
mechanism could explain the taurine effects found in this study. However, it is clear from the present study that 
taurine improves disturbances in the 24 h pattern of plasma insulin and leptin, as well as Per1 expression in pan-
creatic islets caused by HFD feeding. Thus, this is the first evidence that shows that taurine could be a potential 
target to correct or ameliorate the disturbances in circadian rhythms caused by obesity.
Materials and Methods
Animals and experimental groups. Ten-week-old male C57BL/6 mice were fed ad libitum with chow 
diet or high fat diet (45% fat Research diets Inc. D12451) for 10 weeks. The experimental groups were divided: 
Controls fed with chow diet (C), controls fed with chow diet and 2% taurine (Sigma-Aldrich, St. Louis, MO) in 
drinking water (C+ T), mice fed with HFD (HFD) and mice fed with HFD and 2% taurine in water (HFD+ T). 
Mice were allowed free access to food and water and maintained a 12 h light–dark cycle at 24 °C and constant 
humidity in soundproof cages. Body weight and water intake were measured every week during the 10 weeks 
of diet. Food intake was monitored from the first week of treatment by measuring the amount of food con-
sumed from 8:00 to 20:00 (light cycle) and from 20:00 to 8:00 (dark cycle). After 10 weeks of treatment, mice 
Figure 4. Effects of taurine on circadian insulin secretion in vitro. Pancreatic islets were isolated at different 
times of day (6:00 h, 12:00 h, 18:00 h and 24:00 h) after 10 weeks of taurine treatment and stimulated with 
2.8 mM glucose (white bars) and 16.8 mM glucose (black bars) (n = 6–7 mice per group). (A) Insulin secretion 
from C and C+ T groups. Data are expressed as mean ± SEM. Differences between 2.8 mM glucose and 16.8 mM 
glucose in the C (**P < 0.01, ***P < 0.001) and C+ T groups (**P < 0.01, ***P < 0.001). Differences in the time 
of day at 2.8 mM glucose and 16.8 mM glucose in the C and C+ T groups (#P < 0.05, ##P < 0.01, and ###P < 0.001 
respectively). (B) Insulin secretion from HFD and HFD+ T groups (n = 6–7). Differences between 2.8 mM 
glucose and 16.8 mM glucose in the HFD group (*P < 0.05, ***P < 0.001) and HFD+ T group (*P < 0.05). 
Differences in the time of day at 16.8 mM glucose in HFD group (#P < 0.05, ###P < 0.001).
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were euthanized at different times of day: 6:00, 12:00, 18:00 and 24:00 h. Protocols were approved by the Animal 
Research Committee of the University of Barcelona, Spain, and principles of laboratory animal care were fol-
lowed, according to European and local government guidelines.
Daily measurements of glucose, insulin and leptin. The measurements of daily pattern of glucose, 
insulin and leptin were done in the fed state at the end of the long-term treatment of 10 weeks. Animals were 
sacrificed at the following times 6:00, 12:00, 18:00 and 24:00 and blood samples were collected to measure plasma 
insulin and leptin by ELISA (Mercodia Insulin, Uppsala Sweden and Crystal Chem, Harris County, TX, USA, 
respectively). Blood glucose was measured with glucometer (Accu-Check; Roche Diagnostics, Madrid, Spain). 
Glucose and insulin tolerance tests. Glucose tolerance and insulin sensitivity were assessed during the 
last week of treatment. In the intraperitoneal glucose tolerance tests, 4 h-fasted mice were injected with 2 g glu-
cose/kg body weight; blood glucose levels were then measured at 0, 15, 30, 60, 90 and 120 min after injection, 
and glucose was measured at all points using a glucometer (Accu-Check; Roche Diagnostics, Madrid, Spain). 
Moreover, blood samples were collected at the first 4 time points to quantify insulin. For insulin tolerance tests, 
mice were injected with 0.50 IU insulin/kg body weight. Blood samples were collected before insulin injection 
Figure 5. Clock genes expression in islets during 24 h. Pancreatic islets were isolated at different times of day 
(6:00 h, 12:00 h, 18:00 h and 24:00 h) after 10 weeks of taurine treatment. (n = 4–5). (A) Clock gene expression in 
isolated islets.  (C),  (C+ T),  (HFD) and  (HFD+ T). (B) Rev-erb alpha gene expression in 
islets. (C) Bmal1 gene expression in islets. (D) Per2 gene expression in islets. (E) Per1 gene expression in islets. 
Data are expressed as mean ± SEM. Differences between C vs C+ T (&&P < 0.01), C vs HFD (*P < 0.05) and 
HFD vs HFD+ T (#P < 0.05) (n = 6–7 mice per group). The black bars refer on the top of the figures to the dark 
cycle and the white bars to the light cycle.
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(time 0) and at 15, 30, 60, 90 min and 120 min after insulin administration, for glucose measurements. Plasma 
was separated by centrifugation. Plasma levels of insulin and leptin were measured by ELISA (Mercodia Insulin, 
Uppsala Sweden, and Crystal Chem, Harris County, TX, USA, respectively).
Isolation of pancreatic islets. After being fully anesthetized, mice were euthanized by cervical dislocation 
and a collagenase P solution (Sigma-Aldrich, St. Louis, MO, USA) was perfused into the pancreas through a 
direct puncture of the common bile duct to digest the pancreas. After digestion, islets of Langerhans were sepa-
rated from exocrine tissue using a density gradient with Histopaque (Sigma-Aldrich, St. Louis, MO, USA). Islets 
were handpicked in a Leica stereomicroscope for further measurements of gene and protein expression and for 
insulin secretion assays.
Glucose-stimulated insulin secretion in vitro. After 10 weeks of treatment, mice were euthanized at 
6:00, 12:00, 18:00 and 24:00. Groups of 5 fresh isolated islets from 4–5 different mice from each group were first 
pre-incubated at 37 °C in a 5.6 mM glucose KRBH solution for 30 min. Supernatant was discarded, and islets 
were incubated for 60 min at 37 °C in KRBH containing 2.8 mM or 16.7 mM glucose, respectively. After incuba-
tion, supernatants were collected, and insulin was quantified using a mouse insulin ELISA kit (Mercodia Insulin 
Uppsala, Sweden).
Western Blot. Protein extraction of isolated islets was obtained using RIPA lysis buffer (Tris 50 mmol/l, pH 
7.5, EDTA 5 mmol/l, NaCl, 1% 150 mmol/l, Triton X-100 1%, SDS 0.1%, 10 mmol/l sodium fluoride, 1% sodium 
deoxycholate, and protease inhibitors). For the extraction, islet lysates were frozen and thawed twice after cen-
trifugation for 20 min at 4 °C, and supernatants were collected and stored at − 80 °C. Protein quantification was 
determined with the Lowry protein assay kit (Bio-rad, Hercules, CA, USA). The protein was electrotransferred 
onto a PVDF membrane. The membranes were blocked for 1 h with 0.05% Tween-20 and 5% NFDM, and then 
incubated overnight at 4 °C with the antibodies: AntiPer1 (1:500; Thermo Scientific Inc.) ß-Actin was used as a 
loading control (1:5,000; GE Healthcare, Hertfordshire, UK). Protein bands were revealed by using the Pierce 
ECL western blot substrate (Thermo Fisher Scientific, Madrid, Spain). Respective bands were quantified by den-
sitometry. Image J software 1.50a and intensity values for PER 1 were normalized with ß-Actin.
RNA isolation and Real-time PCR. Total RNA was prepared from isolated islets using the RNeasy Mini Kit 
(Qiagen, Hilden, Germany). RNA was quantified using a Nanodrop 1000 (Thermo Scientific Wilmington, MA) 
and then retrotranscribed using the High Capacity cDNA Reverse Transcription Kit (AB Applied Biosystems, 
USA) following the manufacturer’s instructions. The cDNA was amplified by Real-Time PCR in a LightCycler 480 
System (Roche) using Mesa Green qPCR Master Mix (Mesa Green, Eurogentec, Belgium). The expression of clock 
genes in isolated pancreatic islets was measured, with the housekeeping gene 36B4 (ribosomal protein large P0) 
used as the endogenous control for quantification. The results were expressed as the relative expression with 
respect to control levels (2−ΔΔct). The primer sequences are shown in Table 4.
Whole islet immunofluorescence. Fresh isolated islets were washed in buffer with PBS 1x and Triton 
0.2%, then fixed in 4% of Paraformaldehide (Electron Microscopy Sciences, Hatfield, PA, USA) for 20 min, per-
meabilized with PBS with Triton 0.3% and blocked in a PBS solution with Triton 0.5% and FBS 10% for 1 h, 
and incubated overnight with the following primary antibodies: guinea pig anti-insulin 1:500, (Dako, Glostrup, 
Denmark) and anti-Per1 1:100 (Thermo Scientific, CA). Islets were incubated 2 hours with Secondary antibodies 
Cy3-labeled anti-guinea pig (Jackson Immuno research) and Alexa Fluor 488 (anti-rabbit (Molecular Probes, 
USA) were used at 1:200 dilutions, respectively. Nuclear staining was performed by using mounting media 
R2 Mesor p Value Amplitude p Value Acrophase p Value
C C+T HFD HFD+T C C+T HFD HFD+T
C vs 
C+T
C vs 
HFD
HFD 
vsHFD+T C C+T HFD HFD+T
C vs 
C+T
C vs 
HFD
HFD vs 
HFD+T C C+T HFD HFD+T
C vs 
C+T
C vs 
HFD
Rev-erb α 0,74 0,82 0,43 0,42 0,17 0,17 0,11* 0,08 0,91 0,05 0,25 0,17 0,18 0,11 0,09 0,67 0.17 0.55 11,0 17,0& 11,0 11,0 0,05 0,34
Clock 0,23 0,08 0,46 0,30 0,17 0,24 0,18 0,26# 0,13 0,63 0,05 0,16 0,23 0,16 0,28# 0,21 0.89 0.05 23,0 18,0 23,0 18,0 0,91 0,87
Bmal1 0,80 0,65 0,39 0,54 0,04 0,47&&& 0,03** 0,04# 0,001 0,01 0,02 0,04 0,04 0,02* 0,03 0,99 0.02 0.74 6,0 6,0 6,0 23,0& 0,57 0,22
Per1 0,46 0,42 0,36 0,60 0,10 0,12 0,06* 0,10# 0,12 0,05 0,05 0,07 0,09 0,03* 0,09## 0,20 0,04 0,01 17,0 17,0 18,0 18,0 0,40 0,42
Per2 0,41 0,37 0,46 0,36 0,12 0,20&& 0,12 0,12 0,01 0,85 0,90 0,09 0,13 0,08 0,10 0,31 0,50 0,63 17,0 17,0 19,0 19,0 0,20 0,34
Differences between groups. 
C vs C+ T
&p < 0.05
&&p < 0.01
&&&p < 0.01
C vs HFD
*p < 0.05
**p < 0.01
HFD vs 
HFD+ T
#p < 0.05
##p < 0.01
Table 3.  Cosinor analysis of the 24 h expression of clock genes. Cosinor analysis including goodness of the 
fit (R2), mesor, amplitude, and acrophase of the 24 h profiles of clock genes in pancreatic islets. Next Two-way 
ANOVA shows the difference between groups in mesor, amplitude and acrophase respectively. Values shown 
are the means ± SEM.
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Figure 6. Effects of taurine in the expression of PER1 protein in isolated pancreatic islets. Pancreatic islets 
were isolated at 18:00 h after 10 weeks of taurine treatment in all experimental groups. Protein expression was 
detected by western blot and immunofluorescence stained against insulin anti-body (red), PER1 anti-body 
(green) and nuclear fraction by DAPI (blue). (A) PER1 protein expression normalized by actin. (n = 4–5 mice 
per group). (B) Percentage of PER1 expression in total number of cells, percentage of PER1 expression in the 
cytoplasm and the nucleus of insulin-positive cells, percentage of nuclear PER1 in beta-cells and percentage of 
nuclear PER1 in the total number of cells in chow diet groups. Differences between C (white bars) versus C+ 
T (black bars). Data are expressed as mean ± SEM. Differences between C vs C+ T (*P < 0.05) (n = 15–20 islets 
analyzed per condition per group). (C) Percentage of PER1 expression in total number of cells, percentage of 
PER1 expression in the cytoplasm and the nucleus of insulin-positive cells, percentage of nuclear PER1 in beta-
cells and percentage of nuclear PER1 in the total number of cells in high fat diet groups. Differences between 
HFD (white bars) versus HFD+ T (black bars). Data are expressed as mean ± SEM. Differences between HFD vs 
HFD+ T (*P < 0.05, **P < 0.01, ***P < 0.001, n = 15–20 islets analyzed per condition per group).
www.nature.com/scientificreports/
1 2Scientific RepoRts | 6:36801 | DOI: 10.1038/srep36801
with DAPI (Life Technologies, USA). Immunofluorescence was assessed in a confocal laser microscope (Leica. 
Microsystems, Wetzlar Germany). For each individual islet images were acquired every 10 μ m using a 40x oil 
immersion objective.
The same settings (i.e pinhole, smart gain, smart offset, phase, zoom) were maintained for each islet in all 
groups. Images were analyzed by Image J Software 1.50a (NIH, USA). Analysis was done by counting the number 
of stained positive cells represented by percentage.
Statistical analysis. Values are presented as means ± SEM. Differences between two groups were analyzed 
by Student’s t test. The effect of time and groups differences were measured by one-way or two-way ANOVA, with 
Bonferroni post hoc test for multiple comparisons, using GraphPad Prism software where appropriate. All statistical 
tests were performed with a level of significance P < 0.05. Cosinor Analysis was done using the Acrophase program 
(R. Refinetti 2004) for fitting cosine functions to the data using a fixed 24 hour period and included the mesor (mid-
dle value of the fitted cosine representing a rhythm-adjusted mean), the amplitude (difference between the mini-
mum and maximum of the fitted cosine function), the acrophase (the time at which the peak of a rhythm occurs, 
expressed in hours) and fitted cosine values to calculate the goodness of the fit by coefficient of determination R2.
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